NCT00717535

Brief Summary

RATIONALE: Studying umbilical cord blood in the laboratory and gathering information about current and previous pregnancies from African-American umbilical cord blood donors may help doctors learn more about the umbilical cord blood of these donors. PURPOSE: This clinical trial is looking at umbilical cord blood from African-American donors.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Aug 2005

Longer than P75 for all trials

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2005

Completed
3 years until next milestone

First Submitted

Initial submission to the registry

July 16, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 17, 2008

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2009

Completed
Last Updated

April 29, 2013

Status Verified

April 1, 2013

Enrollment Period

4.3 years

First QC Date

July 16, 2008

Last Update Submit

April 25, 2013

Conditions

Health Status Unknown

Keywords

health status unknown

Outcome Measures

Primary Outcomes (2)

  • Correlation between total nucleated cell yield of cord blood units and gestational history, maternal history, and delivery information

    Within a year

  • Improvement in total nucleated cell yield of cord blood units from African-American donors

    Within a year

Interventions

cryopreservationOTHER
questionnaire administrationOTHER
study of socioeconomic and demographic variablesOTHER

Eligibility Criteria

Sexfemale
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

African American cord blood donors

DISEASE CHARACTERISTICS: * African-American participant in the National Marrow Donor Program cord blood collection protocol C-2844 * Recruited from the Labor and Delivery Suites of the Detroit Medical Center or its affiliated sites PATIENT CHARACTERISTICS: * Not specified PRIOR CONCURRENT THERAPY: * Not specified

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Biospecimen

Retention: NONE RETAINED

Cord blood unit (CBU)will be collected in utero and transported to the Stem Cell Processing Laboratory. The volume of the CBU will be measured and cell count will be obtained.

MeSH Terms

Interventions

Cryopreservation

Intervention Hierarchy (Ancestors)

Tissue PreservationHistocytological Preparation TechniquesCytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisHistological TechniquesPreservation, BiologicalTherapeuticsInvestigative Techniques

Study Officials

  • Voravit Ratanatharathorn, MD

    Barbara Ann Karmanos Cancer Institute

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
observational
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2008

First Posted

July 17, 2008

Study Start

August 1, 2005

Primary Completion

November 1, 2009

Study Completion

November 1, 2009

Last Updated

April 29, 2013

Record last verified: 2013-04